Recombinant human erythropoietin produced in milk of transgenic pigs

被引:46
作者
Park, JK
Lee, YK
Lee, P
Chung, HJ
Kim, S
Lee, HG
Seo, MK
Han, JH
Park, CG
Kim, HT
Kim, YK
Min, KS
Kim, JH
Lee, HT
Chang, WK [1 ]
机构
[1] Natl Livestock Res Inst, Anim Biotechnol Div, Suwon 441706, South Korea
[2] In2gen Biotech Co Ltd, Seoul, South Korea
[3] Hankyang Natl Univ, Grad Sch Bio & Informat Technol, Ansung, South Korea
[4] Gyeongsang Natl Univ, Dept Dairy Sci, Chinju, South Korea
[5] Konkuk Univ, Dept Anim Sci, Seoul, South Korea
关键词
erythropoietin; transgenic animals; microinjection; mammary gland; expression;
D O I
10.1016/j.jbiotec.2005.11.021
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We have developed a line of transgenic swine harboring recombinant human erythropoietin through microinjection into fertilized one cell pig zygotes. Milk from generations F(1) and F(2) transgenic females was analyzed, and hEPO was detected in milk from all lactating females at concentrations of approximately 877.9 +/- 92.8 IU/1 ml. The amino acid sequence of rhEPO protein in the transgenic pig milk matched that of commercial rhEPO produced from cultured animal cells. In addition, an F-36 cell line, which proliferates in the presence of hEPO or commercial EPO, was induced to synthesize erythroid by extracts from tg sow milk. This study provides evidence that production of purified rhEPO from transgenic pig milk is a potentially valuable technology, and can be used as a cost-effective alternative in clinical applications as well as providing other clinical advantages. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:362 / 371
页数:10
相关论文
共 50 条
  • [41] Phenotypic and genotypic stability of multiple lines of transgenic pigs expressing recombinant human protein C
    VanCott, KE
    Lubon, H
    Russell, CG
    Butler, SP
    Gwazdauskas, FC
    Knight, J
    Drohan, WN
    Velander, WH
    TRANSGENIC RESEARCH, 1997, 6 (03) : 203 - 212
  • [42] Expression of Eukaryotic Recombinant Proteins and Deriving Them from the Milk of Transgenic Animals
    Khodarovich, Yu. M.
    Goldman, I. L.
    Sadchikova, E. R.
    Georgiev, P. G.
    APPLIED BIOCHEMISTRY AND MICROBIOLOGY, 2013, 49 (09) : 711 - 722
  • [43] COMPARATIVE PHARMACOKINETICS AND DISTRIBUTION OF HUMAN URINARY ERYTHROPOIETIN AND RECOMBINANT-HUMAN-ERYTHROPOIETIN IN RATS
    KINOSHITA, H
    OHISHI, N
    KATO, M
    TOKURA, S
    OKAZAKI, A
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 1991, 41-2 (09): : 1004 - 1007
  • [44] The effect of dissolved oxygen on the production and the glycosylation profile of recombinant human erythropoietin produced from CHO cells
    Restelli, Veronica
    Wang, Ming-Dong
    Huzel, Norman
    Ethier, Martin
    Perreault, Helene
    Butler, Michael
    BIOTECHNOLOGY AND BIOENGINEERING, 2006, 94 (03) : 481 - 494
  • [45] Recombinant human erythropoietin in the treatment of nonrenal anemia
    Michael Heuser
    Arnold Ganser
    Annals of Hematology, 2006, 85 : 69 - 78
  • [46] Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in rats
    Kato, M
    Okano, K
    Sakamoto, Y
    Miura, K
    Uchimura, T
    Saito, K
    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, 2001, 51 (01): : 91 - 95
  • [47] Recombinant human erythropoietin use in intensive care
    Darveau, M
    Notebaert, É
    Denault, AY
    Bélisle, S
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (06) : 1068 - 1074
  • [48] Recombinant human erythropoietin in the treatment of nonrenal anemia
    Heuser, M
    Ganser, A
    ANNALS OF HEMATOLOGY, 2006, 85 (02) : 69 - 78
  • [49] IMMUNOMODULATORY ACTION OF HUMAN RECOMBINANT ERYTHROPOIETIN IN MAN
    IMIELA, J
    KORCZAKKOWALSKA, G
    MALECKI, R
    NOWACZYK, M
    STEPIENSOPNIEWSKA, B
    GORSKI, A
    IMMUNOLOGY LETTERS, 1993, 35 (03) : 271 - 276
  • [50] INTRAPERITONEAL ADMINISTRATION OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    FRENKEN, LAM
    STRUIJK, DG
    COPPENS, PJW
    TIGGELER, RGWL
    KREDIET, RT
    KOENE, RAP
    PERITONEAL DIALYSIS INTERNATIONAL, 1992, 12 (04): : 378 - 383